BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29141020)

  • 1. Genomic analysis of atypical fibroxanthoma.
    Lai K; Harwood CA; Purdie KJ; Proby CM; Leigh IM; Ravi N; Mully TW; Brooks L; Sandoval PM; Rosenblum MD; Arron ST
    PLoS One; 2017; 12(11):e0188272. PubMed ID: 29141020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profiles.
    Griewank KG; Wiesner T; Murali R; Pischler C; Müller H; Koelsche C; Möller I; Franklin C; Cosgarea I; Sucker A; Schadendorf D; Schaller J; Horn S; Brenn T; Mentzel T
    Mod Pathol; 2018 Mar; 31(3):418-428. PubMed ID: 29099504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations.
    Miller TI; Zoumberos NA; Johnson B; Rhodes DR; Tomlins SA; Chan MP; Andea AA; Lucas DR; McHugh JB; Smith N; Harms KL; Brewer C; Saleh J; Patel RM; Harms PW
    Hum Pathol; 2020 Aug; 102():60-69. PubMed ID: 32540221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological and Genomic Profiles of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma Identify Overlapping Signatures with a High Mutational Burden.
    Ak M; Kahraman A; Arnold FM; Turko P; Levesque MP; Zoche M; Ramelyte E; Dummer R
    Genes (Basel); 2021 Jun; 12(7):. PubMed ID: 34202213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogene and therapeutic target analyses in atypical fibroxanthomas and pleomorphic dermal sarcomas.
    Helbig D; Ihle MA; Pütz K; Tantcheva-Poor I; Mauch C; Büttner R; Quaas A
    Oncotarget; 2016 Apr; 7(16):21763-74. PubMed ID: 26943575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma.
    Sakamoto A; Oda Y; Itakura E; Oshiro Y; Nikaido O; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2001 Jun; 14(6):581-8. PubMed ID: 11406660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleomorphic dermal sarcoma in a man with HIV: report with next-generation sequencing analysis and review of the atypical fibroxanthoma/pleomorphic dermal sarcoma spectrum.
    Chen SX; Eichenfield DZ; Orme C; Hinds B
    Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clear cell variant of atypical fibroxanthoma and pleomorphic dermal sarcoma: Molecular characterization and review of the literature.
    Coelho-Lima J; Bruty J; Watkins J; Liu H; Price R; Stefanos N
    J Cutan Pathol; 2022 Dec; 49(12):1031-1034. PubMed ID: 35922373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultraviolet-induced p53 mutations in atypical fibroxanthoma.
    Dei Tos AP; Maestro R; Doglioni C; Gasparotto D; Boiocchi M; Laurino L; Fletcher CD
    Am J Pathol; 1994 Jul; 145(1):11-7. PubMed ID: 8030743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical fibroxanthoma: new insights.
    Hussein MR
    Expert Rev Anticancer Ther; 2014 Sep; 14(9):1075-88. PubMed ID: 24958232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Merkel cell polyomavirus DNA in atypical fibroxanthoma in correlation to clinical features.
    Andres C; Puchta U; Flaig MJ
    Am J Dermatopathol; 2010 Dec; 32(8):799-803. PubMed ID: 20861707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis of the Gadd45 gene at exon 4 in atypical fibroxanthoma.
    Sakamoto A; Akieda S; Oda Y; Iwamoto Y; Tsuneyoshi M
    BMC Dermatol; 2009 Jan; 9():1. PubMed ID: 19128509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical fibroxanthoma: An analysis of 105 tumors.
    Bitel A; Schönlebe J; Krönert C; Wollina U
    Dermatol Ther; 2020 Nov; 33(6):e13962. PubMed ID: 32618393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-551b regulates epithelial-mesenchymal transition and metastasis of gastric cancer by inhibiting ERBB4 expression.
    Song G; Zhang H; Chen C; Gong L; Chen B; Zhao S; Shi J; Xu J; Ye Z
    Oncotarget; 2017 Jul; 8(28):45725-45735. PubMed ID: 28501849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The many faces of Atypical fibroxanthoma.
    Agaimy A
    Semin Diagn Pathol; 2023 Jul; 40(4):306-312. PubMed ID: 37438163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of atypical fibroxanthoma and pleomorphic dermal sarcoma: a retrospective analysis of four German skin cancer centers.
    Kuntz T; Siebdrath J; Hofmann SC; Baltaci M; Schaller J; Hellmich M; von Goltzheim LS; Assaf C; Oellig F; Michalowitz AL; Helbig D; Kreuter A
    J Dtsch Dermatol Ges; 2022 Dec; 20(12):1581-1588. PubMed ID: 36442137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS).
    Helbig D; Ziemer M; Dippel E; Erdmann M; Hillen U; Leiter U; Mentzel T; Osterhoff G; Ugurel S; Utikal J; von Bubnoff D; Weishaupt C; Grabbe S
    J Dtsch Dermatol Ges; 2022 Feb; 20(2):235-243. PubMed ID: 35099104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical fibroxanthoma and pleomorphic dermal sarcoma: Is superficial infiltration in subcutaneous tissue acceptable in AFX?
    van Midden D; Flucke UE; Amir AL; Bonenkamp JJ; Lubeek SFK; Blokx WAM
    Ann Diagn Pathol; 2022 Jun; 58():151915. PubMed ID: 35276548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide methylation profiling and copy number analysis in atypical fibroxanthomas and pleomorphic dermal sarcomas indicate a similar molecular phenotype.
    Koelsche C; Stichel D; Griewank KG; Schrimpf D; Reuss DE; Bewerunge-Hudler M; Vokuhl C; Dinjens WNM; Petersen I; Mittelbronn M; Cuevas-Bourdier A; Buslei R; Pfister SM; Flucke U; Mechtersheimer G; Mentzel T; von Deimling A
    Clin Sarcoma Res; 2019; 9():2. PubMed ID: 30809375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified.
    Laginestra MA; Cascione L; Motta G; Fuligni F; Agostinelli C; Rossi M; Sapienza MR; Righi S; Broccoli A; Indio V; Melle F; Tabanelli V; Calleri A; Novero D; Facchetti F; Inghirami G; Sabattini E; Bertoni F; Pileri SA
    Mod Pathol; 2020 Feb; 33(2):179-187. PubMed ID: 31028364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.